Kong

AI Drug Firm METiS Considering $200 Million Hong Kong IPO, Sources Say

Artificial intelligence-driven drug firm METiS Pharmaceuticals is considering an initial public offering in Hong Kong to raise as much as $200 million, according...

Kirsten Collins1 Mins read